Developer docs
API playgroundTry for free, no card

Search company profiles

American Association for the Study of Liver Diseases - AASLD

Full company profile

uuid0007gwf

Namestring
American Association for the Study of Liver Diseases - AASLD
Legal namestring
American Association for the Study of Liver Diseases
Websiteurl
aasld.org
Company typeenum
Private
Founded yearint
1950
Descriptiontext

AASLD is a U.S.-based nonprofit professional medical association founded in 1950 and headquartered in Alexandria, Virginia, serving hepatologists, gastroenterologists, hepatology fellows, advanced practice providers, and liver disease researchers worldwide. Its core function is to advance hepatology through the dissemination of peer-reviewed research, evidence-based clinical practice guidelines, and continuing medical education.

The organization's product portfolio centers on three peer-reviewed journals (HEPATOLOGY, Liver Transplantation, and Hepatology Communications) published via Lippincott Williams & Wilkins; the LiverLearning online learning management system delivering ACCME-accredited CME courses, webinars, and conference recordings; evidence-based Practice Guidelines covering liver disease diagnosis, treatment, and prevention; and The Liver Meeting, its flagship annual scientific conference with rotating U.S. locations. Supporting infrastructure includes the AASLD Foundation (a charitable arm funding research and career development awards), the Career Center job board, Special Interest Groups, and policy advocacy programs such as the HCV Elimination Coalition.

AASLD's revenue model combines individual membership dues, tiered event and conference registration fees (ranging from $0 for students/patients to $450 for industry attendees), journal institutional subscriptions, and philanthropic contributions via the AASLD Foundation. The organization maintains ACCME accreditation to issue AMA PRA Category 1 Credits and operates with a lean staff of 11-50 employees while serving a global membership community. Recent strategic emphasis has been on MASLD/MASH education responding to projected U.S. prevalence of 122 million cases by 2050, expansion into frontline clinician audiences, and global outreach initiatives supported by GDPR- and CCPA-compliant data practices.

Short descriptiontext

AASLD is a nonprofit professional medical association founded in 1950 serving hepatologists, gastroenterologists, and liver disease researchers worldwide through peer-reviewed journals, ACCME-accredited CME, practice guidelines, and the annual Liver Meeting conference.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAlexandria, United States
HQ citystring
Alexandria
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
hepatology professional education, liver disease research, clinical practice guidelines, continuing medical education, peer-reviewed scientific journals
Industry3 codes
1Hepatology & Liver Disease
CodeHLAKAEABPrimaryYes
2Transplant Hepatology
CodeHLAKAEAKPrimaryNo
3Hepatology (Viral Hepatitis)
CodeHLAKAGACPrimaryNo
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Educational Support Services611710
Product category
Medical Professional Association - Hepatology
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details3 tiers
1Membership-based pricing with member discounts
ModelSubscriptionBilling cadenceAnnual
Notes

Annual membership provides exclusive access to journals, LiverLearning courses, discounts on event prices, and member-only resources

aasld.org
2Liver Care for Frontline Clinicians - Denver Event Registration
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Physician: $250; Resident/Trainee: $100; Associates (RN, NP, PharmD): $100; Student: $50; Industry: $450. Includes lunch and snacks.

aasld.org
32026 Emerging Topic Conference On-Demand
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Member: $200; Non-Member: $400; Patient: $0; Associate: $125; Student: $0; Early Career: $125; Industry Rep: $400

liverlearning.aasld.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 9 records shown
1LiverLearning
Description

Online educational platform offering courses, webinars, and continuing education for hepatology professionals

aasld.org
+8 more records
Core offering1 text field

AASLD is a nonprofit professional medical association that advances hepatology through membership services, accredited continuing medical education delivered via the LiverLearning platform, peer-reviewed scientific journals (HEPATOLOGY, Liver Transplantation, Hepatology Communications), evidence-based clinical practice guidelines, and the annual Liver Meeting conference. Its productized offerings — journal subscriptions, CME-eligible courses and webinars, conference registration, and clinical guidelines — are sold or accessed primarily by individual hepatology professionals, trainees, and research institutions worldwide.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

AASLD operates a multi-product portfolio centered on advancing hepatology research, education, and clinical practice. The core offerings include LiverLearning (a comprehensive online education platform providing CME courses, webinars, and conference recordings), three peer-reviewed journals (HEPATOLOGY, Liver Transplantation, and Hepatology Communications), and evidence-based Practice Guidelines covering various liver diseases. Additional resources include HCV Guidelines, the Career Center for professional development, and The Liver Meeting (an annual scientific conference). The organization also provides continuing education through webinars, the Emerging Topic Conference series, and transplant hepatology board review courses.

Product and service9 records
1LiverLearning
CategoryEducation Platform
Description

AASLD's online learning management system offering CME courses, webinars, conference recordings, and certification materials for hepatology professionals including fellows, advanced practice providers, and practicing clinicians.

2HEPATOLOGY Journal
CategoryScientific Journal
Description

AASLD's premier peer-reviewed scientific journal publishing original research on all aspects of liver structure, function, and disease; available through institutional and individual subscription.

3Liver Transplantation Journal
CategoryScientific Journal
Description

A peer-reviewed journal publishing articles on liver transplantation, liver surgery, and chronic liver disease, published jointly with the International Liver Transplantation Society.

4Hepatology Communications
CategoryScientific Journal
Description

An AASLD peer-reviewed journal focused on publishing research communications in hepatology, available to members and institutional subscribers.

5Clinical Practice Guidelines
CategoryClinical Resource
Description

Evidence-based clinical practice guidelines developed by expert panels covering diagnosis, treatment, and prevention of liver diseases, made available online to clinicians.

6The Liver Meeting (Annual Conference)
CategoryConference
Description

AASLD's premier annual scientific meeting where hepatology professionals present and discuss the latest research and clinical advances, with both in-person and Digital Experience virtual attendance options.

7AASLD Career Center
CategoryProfessional Resource
Description

Online job board and career resources platform for hepatology professionals seeking employment opportunities and professional development resources.

8HCV Guidelines
CategoryClinical Resource
Description

Evidence-based clinical guidelines for the prevention, surveillance, and treatment of hepatitis C virus infection, developed for clinicians managing HCV.

9Fundamentals of Liver Disease (Course Series)
CategoryOnline Education Course
Description

A series of introductory courses covering common liver diseases (MASLD, cirrhosis, hepatitis B, abnormal liver tests) for clinicians new to hepatology, available on the LiverLearning LMS.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The leading European professional society dedicated to hepatology, publishing the Journal of Hepatology and hosting the annual International Liver Congress. EASL is the international counterpart to AASLD with overlapping journals, congresses, guidelines, and CME offerings for liver-disease specialists.

TypeDirect peer
Description

U.S. professional society for gastroenterology that publishes Gastroenterology and Hepatology, hosts Digestive Disease Week, and develops clinical guidelines. AGA's hepatology vertical directly overlaps AASLD's GI/hepatology member base and guideline scope.

TypeDirect peer
Description

Regional hepatology society covering the Asia-Pacific region, publishing Hepatology International and running an annual conference. APASL competes with AASLD for international hepatology thought leadership in a high-burden region.

TypeBroad incumbent
Description

Large U.S. nonprofit health organization running peer-reviewed journals (Circulation, Hypertension), annual Scientific Sessions, CME, and advocacy. AHA mirrors AASLD's full-stack operating model (journals, conferences, CME, advocacy) at a much larger scale.

TypeBroad incumbent
Description

Voluntary health organization serving diabetes clinicians and patients, publishing Diabetes Care and Diabetes, running Scientific Sessions, and certifying education. ADA's chronic-disease specialty society structure closely parallels AASLD's hepatology mission.

TypeBroad incumbent
Description

Major oncology professional society publishing the Journal of Clinical Oncology and hosting the ASCO Annual Meeting. ASCO's journal-plus-meeting-plus-guidelines-plus-CME model is a high-end analogue of AASLD's hepatology platform.

TypeBroad incumbent
Description

Large internal-medicine professional society publishing Annals of Internal Medicine and running Internal Medicine Meeting and CME programs. ACP shares AASLD's reliance on membership, journals, live meetings, and clinical guidelines.

TypeBroad incumbent
Description

U.S. pulmonary and critical-care specialty society publishing the American Journal of Respiratory and Critical Care Medicine and running the International Conference. ATS mirrors AASLD's specialty-journal-and-meeting structure for clinicians.

TypeRegional player
Description

U.S.-centric infectious-disease society publishing Clinical Infectious Diseases and Journal of Infectious Diseases and developing HIV/HCV clinical guidelines that overlap with AASLD's viral-hepatitis and HCV Guidelines content.

TypeOthers
Description

Publisher and platform operator that distributes AASLD's journals (HEPATOLOGY, Liver Transplantation, Hepatology Communications) via Lippincott and provides CME infrastructure; also operates competing medical-education and accreditation platforms that rival LiverLearning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

American Association for the Study of Liver Diseases - AASLD

Medical Professional Association - Hepatologyaasld.org

AASLD is a nonprofit professional medical association founded in 1950 serving hepatologists, gastroenterologists, and liver disease researchers worldwide through peer-reviewed journals, ACCME-accredited CME, practice guidelines, and the annual Liver Meeting conference.

What American Association for the Study of Liver Diseases - AASLD does

AASLD is a U.S.-based nonprofit professional medical association founded in 1950 and headquartered in Alexandria, Virginia, serving hepatologists, gastroenterologists, hepatology fellows, advanced practice providers, and liver disease researchers worldwide. Its core function is to advance hepatology through the dissemination of peer-reviewed research, evidence-based clinical practice guidelines, and continuing medical education.

The organization's product portfolio centers on three peer-reviewed journals (HEPATOLOGY, Liver Transplantation, and Hepatology Communications) published via Lippincott Williams & Wilkins; the LiverLearning online learning management system delivering ACCME-accredited CME courses, webinars, and conference recordings; evidence-based Practice Guidelines covering liver disease diagnosis, treatment, and prevention; and The Liver Meeting, its flagship annual scientific conference with rotating U.S. locations. Supporting infrastructure includes the AASLD Foundation (a charitable arm funding research and career development awards), the Career Center job board, Special Interest Groups, and policy advocacy programs such as the HCV Elimination Coalition.

AASLD's revenue model combines individual membership dues, tiered event and conference registration fees (ranging from $0 for students/patients to $450 for industry attendees), journal institutional subscriptions, and philanthropic contributions via the AASLD Foundation. The organization maintains ACCME accreditation to issue AMA PRA Category 1 Credits and operates with a lean staff of 11-50 employees while serving a global membership community. Recent strategic emphasis has been on MASLD/MASH education responding to projected U.S. prevalence of 122 million cases by 2050, expansion into frontline clinician audiences, and global outreach initiatives supported by GDPR- and CCPA-compliant data practices.

American Association for the Study of Liver Diseases - AASLD firmographics

Firmographics
Name
American Association for the Study of Liver Diseases - AASLD
Legal name
American Association for the Study of Liver Diseases
Website
https://aasld.org
Company type
Private
Founded year
1950
Operating status
Operating
Headcount range
11–50 employees
Short description
AASLD is a nonprofit professional medical association founded in 1950 serving hepatologists, gastroenterologists, and liver disease researchers worldwide through peer-reviewed journals, ACCME-accredited CME, practice guidelines, and the annual Liver Meeting conference.
Ownership category
akta.pro rank

American Association for the Study of Liver Diseases - AASLD industry classification

Industry
Product category
Medical Professional Association - Hepatology
NAICS
Voluntary Health Organizations (813212), Educational Support Services (611710)
akta.pro primary industry
Hepatology & Liver Disease (HLAKAEAB)
akta.pro secondary industries
Transplant Hepatology (HLAKAEAK), Hepatology (Viral Hepatitis) (HLAKAGAC)

Keywords

  • Hepatology professional education
  • Liver disease research
  • Clinical practice guidelines
  • Continuing medical education
  • Peer-reviewed scientific journals

Where American Association for the Study of Liver Diseases - AASLD is headquartered

Location

Headquarters

HQ city
Alexandria
HQ country
United States
HQ region
North America

Markets served

American Association for the Study of Liver Diseases - AASLD business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Pricing tiers

ModelBillingPrice
SubscriptionAnnualMembership-based pricing with member discounts
One time/ perpetual licensePay-as-you-goLiver Care for Frontline Clinicians - Denver Event Registration
One time/ perpetual licensePay-as-you-go2026 Emerging Topic Conference On-Demand

Distribution channels4 records

Marketing channels7 records

American Association for the Study of Liver Diseases - AASLD product offering

Product offering

Core offering

AASLD is a nonprofit professional medical association that advances hepatology through membership services, accredited continuing medical education delivered via the LiverLearning platform, peer-reviewed scientific journals (HEPATOLOGY, Liver Transplantation, Hepatology Communications), evidence-based clinical practice guidelines, and the annual Liver Meeting conference. Its productized offerings — journal subscriptions, CME-eligible courses and webinars, conference registration, and clinical guidelines — are sold or accessed primarily by individual hepatology professionals, trainees, and research institutions worldwide.

Product overview

AASLD operates a multi-product portfolio centered on advancing hepatology research, education, and clinical practice. The core offerings include LiverLearning (a comprehensive online education platform providing CME courses, webinars, and conference recordings), three peer-reviewed journals (HEPATOLOGY, Liver Transplantation, and Hepatology Communications), and evidence-based Practice Guidelines covering various liver diseases. Additional resources include HCV Guidelines, the Career Center for professional development, and The Liver Meeting (an annual scientific conference). The organization also provides continuing education through webinars, the Emerging Topic Conference series, and transplant hepatology board review courses.

Differentiator

Problem solved

Functional benefit

Brands

  • LiverLearning: Online educational platform offering courses, webinars, and continuing education for hepatology professionals
  • HEPATOLOGY
  • Hepatology Communications
  • Liver Transplantation
  • Clinical Liver Disease
  • The Liver Meeting
  • The Liver Meeting Digital Experience
  • AASLD Foundation
  • Liver Fellow Network

Products and services

  • LiverLearning AASLD's online learning management system offering CME courses, webinars, conference recordings, and certification materials for hepatology professionals including fellows, advanced practice providers, and practicing clinicians.
  • HEPATOLOGY Journal AASLD's premier peer-reviewed scientific journal publishing original research on all aspects of liver structure, function, and disease; available through institutional and individual subscription.
  • Liver Transplantation Journal A peer-reviewed journal publishing articles on liver transplantation, liver surgery, and chronic liver disease, published jointly with the International Liver Transplantation Society.
  • Hepatology Communications An AASLD peer-reviewed journal focused on publishing research communications in hepatology, available to members and institutional subscribers.
  • Clinical Practice Guidelines Evidence-based clinical practice guidelines developed by expert panels covering diagnosis, treatment, and prevention of liver diseases, made available online to clinicians.
  • The Liver Meeting (Annual Conference) AASLD's premier annual scientific meeting where hepatology professionals present and discuss the latest research and clinical advances, with both in-person and Digital Experience virtual attendance options.
  • AASLD Career Center Online job board and career resources platform for hepatology professionals seeking employment opportunities and professional development resources.
  • HCV Guidelines Evidence-based clinical guidelines for the prevention, surveillance, and treatment of hepatitis C virus infection, developed for clinicians managing HCV.
  • Fundamentals of Liver Disease (Course Series) A series of introductory courses covering common liver diseases (MASLD, cirrhosis, hepatitis B, abnormal liver tests) for clinicians new to hepatology, available on the LiverLearning LMS.

Companies that use American Association for the Study of Liver Diseases - AASLD

Customer profile

Segments4 records

Ideal customer profiles4 records

American Association for the Study of Liver Diseases - AASLD technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

American Association for the Study of Liver Diseases - AASLD partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights6 records

American Association for the Study of Liver Diseases - AASLD competitors and assessment

Company assessment

Direct peers

  • European Association for the Study of the Liver (EASL): The leading European professional society dedicated to hepatology, publishing the Journal of Hepatology and hosting the annual International Liver Congress. EASL is the international counterpart to AASLD with overlapping journals, congresses, guidelines, and CME offerings for liver-disease specialists.
  • American Gastroenterological Association (AGA): U.S. professional society for gastroenterology that publishes Gastroenterology and Hepatology, hosts Digestive Disease Week, and develops clinical guidelines. AGA's hepatology vertical directly overlaps AASLD's GI/hepatology member base and guideline scope.
  • Asian Pacific Association for the Study of the Liver (APASL): Regional hepatology society covering the Asia-Pacific region, publishing Hepatology International and running an annual conference. APASL competes with AASLD for international hepatology thought leadership in a high-burden region.

Broad incumbents

  • American Heart Association (AHA): Large U.S. nonprofit health organization running peer-reviewed journals (Circulation, Hypertension), annual Scientific Sessions, CME, and advocacy. AHA mirrors AASLD's full-stack operating model (journals, conferences, CME, advocacy) at a much larger scale.
  • American Diabetes Association (ADA): Voluntary health organization serving diabetes clinicians and patients, publishing Diabetes Care and Diabetes, running Scientific Sessions, and certifying education. ADA's chronic-disease specialty society structure closely parallels AASLD's hepatology mission.
  • American Society of Clinical Oncology (ASCO): Major oncology professional society publishing the Journal of Clinical Oncology and hosting the ASCO Annual Meeting. ASCO's journal-plus-meeting-plus-guidelines-plus-CME model is a high-end analogue of AASLD's hepatology platform.
  • American College of Physicians (ACP): Large internal-medicine professional society publishing Annals of Internal Medicine and running Internal Medicine Meeting and CME programs. ACP shares AASLD's reliance on membership, journals, live meetings, and clinical guidelines.
  • American Thoracic Society (ATS): U.S. pulmonary and critical-care specialty society publishing the American Journal of Respiratory and Critical Care Medicine and running the International Conference. ATS mirrors AASLD's specialty-journal-and-meeting structure for clinicians.

Regional players

  • Infectious Diseases Society of America (IDSA): U.S.-centric infectious-disease society publishing Clinical Infectious Diseases and Journal of Infectious Diseases and developing HIV/HCV clinical guidelines that overlap with AASLD's viral-hepatitis and HCV Guidelines content.

Others

  • Wolters Kluwer / Lippincott CME and journal platforms: Publisher and platform operator that distributes AASLD's journals (HEPATOLOGY, Liver Transplantation, Hepatology Communications) via Lippincott and provides CME infrastructure; also operates competing medical-education and accreditation platforms that rival LiverLearning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

American Association for the Study of Liver Diseases - AASLD social profiles

Digital presence

American Association for the Study of Liver Diseases - AASLD compliance and trust

Trust signal

Compliance6 records

American Association for the Study of Liver Diseases - AASLD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

American Association for the Study of Liver Diseases - AASLD leadership team

Management profile

Number of profiles

Profiles4 records

American Association for the Study of Liver Diseases - AASLD subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

American Association for the Study of Liver Diseases - AASLD funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

American Association for the Study of Liver Diseases - AASLD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Association for the Study of Liver Diseases - AASLD

What does American Association for the Study of Liver Diseases - AASLD do?

AASLD is a nonprofit professional medical association that advances hepatology through membership services, accredited continuing medical education delivered via the LiverLearning platform, peer-reviewed scientific journals (HEPATOLOGY, Liver Transplantation, Hepatology Communications), evidence-based clinical practice guidelines, and the annual Liver Meeting conference. Its productized offerings — journal subscriptions, CME-eligible courses and webinars, conference registration, and clinical guidelines — are sold or accessed primarily by individual hepatology professionals, trainees, and research institutions worldwide.

Is American Association for the Study of Liver Diseases - AASLD a public or private company?

American Association for the Study of Liver Diseases - AASLD is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was American Association for the Study of Liver Diseases - AASLD founded?

American Association for the Study of Liver Diseases - AASLD was founded in 1950. It employs 11 to 50 people.

Where is American Association for the Study of Liver Diseases - AASLD based?

American Association for the Study of Liver Diseases - AASLD is headquartered in Alexandria, United States, in the North America region.

Who are American Association for the Study of Liver Diseases - AASLD's main competitors?

Direct peers on record are European Association for the Study of the Liver (EASL), American Gastroenterological Association (AGA) and Asian Pacific Association for the Study of the Liver (APASL). Broad incumbents are American Heart Association (AHA), American Diabetes Association (ADA), American Society of Clinical Oncology (ASCO), American College of Physicians (ACP) and American Thoracic Society (ATS). Infectious Diseases Society of America (IDSA) is listed as a regional player. Wolters Kluwer / Lippincott CME and journal platforms is listed as an others.

Does American Association for the Study of Liver Diseases - AASLD have an API?

No public API is recorded for American Association for the Study of Liver Diseases - AASLD.

What industry is American Association for the Study of Liver Diseases - AASLD in?

American Association for the Study of Liver Diseases - AASLD's product category is Medical Professional Association - Hepatology. Its primary akta.pro industry code is HLAKAEAB, Hepatology & Liver Disease, with a secondary code of HLAKAEAK, Transplant Hepatology. Its NAICS code is 813212.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GastroenterologyadvisorAASLD AST NASPGHAN Guideline Update on Pediatric Liver Transplant EvaluationThe American Association for the Study of Liver Diseases (AASLD), in collaboration with the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the American Society of Transplantation (AST), has published updated clinical practice guidelines for evaluating pediatric candidates for liver transplants. The guidelines include 89 evidence-based recommendations aimed at improving outcomes for children by advocating for early multidisciplinary evaluations and timely referrals, addressing various clinical questions and the unique needs of pediatric patients. The recommendations also emphasize the importance of comprehensive pre-transplant assessments and the vaccination of candidates and their household contacts.The Times of IndiaTimely threapy can avert multi-organ, liver failure: StudyA study presented at the American Association for the Study of Liver Diseases (AASLD) found that Therapeutic Plasma Exchange (TPE) significantly reduces 90-day mortality rates in patients with acute-on-chronic liver failure (ACLF). The analysis of data from the Asian Pacific Association for the Study of the Liver (AARC) database, involving 1,992 patients worldwide, highlighted that TPE is particularly beneficial for those with infections. Experts emphasize initiating this treatment early to stabilize patients and prevent irreversible multi-organ failure while preparing for potential liver transplants.GlobeNewswireACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk among People Living with HIV and MASLD Who Receive SemaglutideACTG presented SLIM LIVER study data at the 2025 AASLD Liver Meeting showing semaglutide improved cardiovascular risk biomarkers in people living with HIV and MASLD. The analysis of 36 participants found significant reductions in lipoproteins and glycoproteins independent of weight or liver fat changes. Larger studies with clinical endpoints are still needed.BioSpacePrecision BioSciences Presents Late-Breaking Phase 1 PBGENE-HBV Data at AASLD The Liver Meeting® Showing Safety, Tolerability and Cumulative, Dose-Dependent Antiviral Activity in First Three CohortsPrecision BioSciences presented late-breaking Phase 1 data for PBGENE-HBV at the AASLD The Liver Meeting 2025, demonstrating safety, tolerability, and dose-dependent antiviral activity across nine patients in the first three cohorts of the ELIMINATE-B study, with no dose-limiting toxicities observed. The highest dose cohort (0.8 mg/kg) showed steep HBsAg declines with evidence of cumulative reductions after repeat administrations. Paired liver biopsy data from one patient provided the first direct molecular evidence of HBV viral gene editing in humans, supporting the therapy's mechanism of targeting cccDNA elimination for a potential cure.GlobeNewswireIpsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigueIpsen will present new PBC data from the ELATIVE trial at AASLD 2025, showing sustained biochemical response and fatigue improvements over three years. At week 182, 72% of patients maintained biochemical response with a 47% ALP reduction, and fatigue-associated protein changes support mechanistic insights.GlobeNewswireGyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025Gyre Therapeutics will present positive Phase 3 trial results for Hydronidone in chronic hepatitis B liver fibrosis at AASLD The Liver Meeting 2025. The abstract was selected as a Poster of Distinction. The trial evaluates Hydronidone's anti-fibrotic effects on hepatic stellate cells.GlobeNewswireInventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025Inventiva announced four abstract presentations at AASLD The Liver Meeting 2025, including digital pathology data from the NATiV3 Phase 3 trial and preclinical studies of lanifibranor. The company will also exhibit at booth #745. Lanifibranor, a pan-PPAR agonist, has Breakthrough Therapy and Fast Track designation for MASH.GlobeNewswireOrganovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver DiseasesOrganovo will present clinical data on FXR314, a non-bile acid FXR agonist, from a Phase 2 MASH study at the AASLD Liver Meeting in San Diego. The oral presentation by Dr. Eric Lawitz will cover pharmacokinetics, safety, and efficacy. The meeting runs November 15-19, 2024.PR NewswireWorld's Largest Liver Disease-Focused Registry Surpasses 400,000 Patient Enrollment MilestoneTarget RWE announced its liver disease registry TARGET-LD has exceeded 400,000 enrolled patients, with more than 15 million months of patient follow-up covering conditions including MASLD, MASH, cirrhosis, PBC, HCC, and hepatitis. The registry supports the company's strategic partnership with the American Association for the Study of Liver Diseases (AASLD) and the Cirrhosis Quality Collaborative (CQC) initiative. The company will present new TARGET-NASH research at the 2024 European Association for the Study of the Liver Congress in Milan, while a recent publication in the American Journal of Gastroenterology confirmed 99% concordance between legacy NASH definitions and new MASLD diagnostic criteria.PR NewswireMerck Manuals: The Facts on Fatty Liver and its New NameIn 2023, the American Association for the Study of Liver Disease (AASLD) updated the medical nomenclature for fatty liver disease, renaming the overall category to steatotic liver disease (SLD) and rechristening nonalcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated steatotic liver disease (MASLD), a change aimed at reducing patient stigma. The article, authored by Dr. Danielle Tholey of Sidney Kimmel Medical College and published by Merck Manuals, explains that metabolic factors such as obesity, insulin resistance, and high blood fats are key contributors to MASLD, and notes that the condition can be improved or even reversed through lifestyle changes including healthy diet, regular exercise, weight management, and limiting alcohol consumption. Merck Manuals, originally published in 1899, operates under Merck (known as MSD outside the US and Canada) and provides medical information across nearly 250 countries.